Questions discussed in this category
Do you avoid certain antidepressants related to the risks on suppressing respiratory-drive which is potentially concerning in patients with high cord ...
How do you approach this in patients who are approaching or are over 65 given the contraindications of benzodiazepine use in geriatric populations? Wh...
How do you balance the benefits of treating depression versus the risk of transition to mania? Do you consider stopping the medication as soon as the ...
Do you defer or avoid use in patients with untreated simple hypertension or other cardiac history?
How is it that I'm able to prescribe medications to patients (in my state) via legitimate mail order pharmacies that are located in a different state?...
Would you consider charging a small fee for managing C-2 prescriptions between appointments instead of requiring the patient to come monthly?
Considering a growing interest in the use of dextromethorphan for depression (Majeed et al., PMID 33682569).
Have you found significant differences among SSRIs and SNRIs (e.g., paroxetine vs fluoxetine vs sertraline vs escitalopram vs duloxetine)? What data d...
Does your approach change when using a long-acting injection antipsychotic with oral antipsychotic medication?
How have you accessed neurosteroids (allopregnanolone) for patients?
How do you evaluate for time off? Return to work? How do you deal with time off requests in the presence of non-adherence to treatment recommendations...
Do you worry about additional increased risk of seizure for patients using medications to assist in weight loss such as GLP-1 agonists?
I have observed a trend where patients who are being tapered off of long-term benzodiazepine (especially in the geriatric population) prescriptions ar...
Do you use different approaches in different settings (i.e., the ED vs. outpatient clinic)? Do you use different approaches for chronic vs acute suici...
Should one restart lamotrigine or look for an alternative? If no other alternative available, is slow titration vs regular titration preferred?
Do you avoid due to the increased risk of GI adverse events?
There does not appear to be any guidance from the most recent published protocols on this topic. For individuals with dementia, recommendations call f...
21686218662156921867219462143120775218682108121318198372140621834216721987221313213312147521235211042162721563198692131721314198761987419875198712116717868212332123120914211662116812813198681987319838136431865516768114771641311290140871049078573767
Papers discussed in this category
Journal of psychiatric practice, 2018-11
Journal of the American Academy of Dermatology, 2019-05
Med Hypotheses, 2006 Nov 28
J Am Acad Dermatol, 2021 Apr 18
Prog Neuropsychopharmacol Biol Psychiatry,
Antimicrob Agents Chemother, 2008 Nov 17
Headache, 2010-06
Headache, 2012 Jan 30
Neurology, 2019 Dec 02
Headache, 2023 Jan 27
Cureus, 2023 May 11
JAMA neurology, 2018-05-01
Journal of the American College of Cardiology, 2020 Aug 18
Annals of internal medicine, 2024 Jul 02
Oxford medical case reports, 2024 Feb 16
Cureus, 2024 Feb 02
Cureus, 2023 Nov 22
CNS drugs, 2024 Mar 19
Neurology, 1991 Mar
Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists, 2013 Aug 31
Clinical neuropharmacology, 1997-08
JAMA psychiatry, 2019 May 01
Journal of clinical psychopharmacology, 2013 Aug
Schizophrenia bulletin, 2022 Nov 18
CNS drugs, 2019 Aug
Clinical toxicology (Philadelphia, Pa.), 2008-09
BMJ case reports, 2017-08-07
The primary care companion for CNS disorders, 2018 Dec 20
Therapeutic advances in psychopharmacology, 2022 May 24
Journal of clinical psychopharmacology, 1990-02